Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-007065
Filing Date
2021-05-13
Accepted
2021-05-13 16:02:50
Documents
72
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lqda-20210331x10q.htm   iXBRL 10-Q 1624878
2 EX-31.1 lqda-20210331xex31d1.htm EX-31.1 15272
3 EX-31.2 lqda-20210331xex31d2.htm EX-31.2 15300
4 EX-32.1 lqda-20210331xex32d1.htm EX-32.1 7532
5 EX-32.2 lqda-20210331xex32d2.htm EX-32.2 7538
6 GRAPHIC lqda-20210331x10q001.jpg GRAPHIC 631
7 GRAPHIC lqda-20210331x10q002.jpg GRAPHIC 647
  Complete submission text file 0001558370-21-007065.txt   7061008

Data Files

Seq Description Document Type Size
8 EX-101.SCH lqda-20210331.xsd EX-101.SCH 50874
9 EX-101.CAL lqda-20210331_cal.xml EX-101.CAL 45158
10 EX-101.DEF lqda-20210331_def.xml EX-101.DEF 189139
11 EX-101.LAB lqda-20210331_lab.xml EX-101.LAB 488666
12 EX-101.PRE lqda-20210331_pre.xml EX-101.PRE 375273
13 EXTRACTED XBRL INSTANCE DOCUMENT lqda-20210331x10q_htm.xml XML 1188200
Mailing Address P.O. BOX 110085 RESEARCH TRIANGLE PARK NC 27709
Business Address P.O. BOX 110085 RESEARCH TRIANGLE PARK NC 27709 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

EIN.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39724 | Film No.: 21919505
SIC: 2834 Pharmaceutical Preparations